These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2785640)
21. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. Condiotti R; Nagler A Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131 [TBL] [Abstract][Full Text] [Related]
22. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301 [TBL] [Abstract][Full Text] [Related]
23. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]
24. Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins. Voiculescu CL; Rosu L; Rogoz S Lymphology; 1988 Sep; 21(3):144-51. PubMed ID: 3264360 [TBL] [Abstract][Full Text] [Related]
25. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
26. Lymphokine-activated and natural killer cell activity in human intestinal mucosa. Hogan PG; Hapel AJ; Doe WF J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2. Hinuma S; Naruo K; Shiho O; Tsukamoto K Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435 [TBL] [Abstract][Full Text] [Related]
28. Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells. Lu L; Herberman RB; DeLeo AB Nat Immun; 1994; 13(6):315-30. PubMed ID: 7894202 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related]
30. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890 [TBL] [Abstract][Full Text] [Related]
31. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF. Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253 [TBL] [Abstract][Full Text] [Related]
32. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice. Argentati K; Bartozzi B; Bernardini G; Di Stasio G; Provinciali M Eur Cytokine Netw; 2000 Mar; 11(1):59-66. PubMed ID: 10705300 [TBL] [Abstract][Full Text] [Related]
34. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
35. Purification and target cell range of in vivo elicited blast natural killer cells. Biron CA; Pedersen KF; Welsh RM J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814 [TBL] [Abstract][Full Text] [Related]
36. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells. Saxena RK; Saxena QB; Adler WH J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628 [TBL] [Abstract][Full Text] [Related]
37. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT). Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. Atedzoe BN; Ahmad A; Menezes J J Immunol; 1997 Nov; 159(10):4966-72. PubMed ID: 9366423 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-2-induced decrease in the buoyant density of cytotoxic cells and its relationship with proliferation. Sarin A; Saxena RK Nat Immun Cell Growth Regul; 1989; 8(5):279-89. PubMed ID: 2556638 [TBL] [Abstract][Full Text] [Related]
40. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]